| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.0007 |